U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C13H10S
Molecular Weight 198.283
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of THIOXANTHINE

SMILES

C1C2=CC=CC=C2SC3=C1C=CC=C3

InChI

InChIKey=PQJUJGAVDBINPI-UHFFFAOYSA-N
InChI=1S/C13H10S/c1-3-7-12-10(5-1)9-11-6-2-4-8-13(11)14-12/h1-8H,9H2

HIDE SMILES / InChI

Molecular Formula C13H10S
Molecular Weight 198.283
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Approval Year

PubMed

PubMed

TitleDatePubMed
Methotrimeprazine-induced corneal deposits and cataract revealed by urine drug profiling test.
2010-11
Drug reprofiling using zebrafish identifies novel compounds with potential pro-myelination effects.
2010-09
Research on antipsychotics in India.
2010-01
Radiation resistance in glioma cells determined by DNA damage repair activity of Ape1/Ref-1.
2010
Energetic studies and phase diagram of thioxanthene.
2009-11-19
Selective MMP-12 inhibitors: WO-2008057254.
2009-07
Development and validation of an HPLC method for the rapid and simultaneous determination of 6-mercaptopurine and four of its metabolites in plasma and red blood cells.
2009-02-20
Spectroscopic and electrochemical analysis of psychotropic drugs.
2009-01
Driving forces for the mutual conversions between phenothiazines and their various reaction intermediates in acetonitrile.
2008-09-18
Application of chaotropic effect in reversed-phase liquid chromatography of structurally related phenothiazine and thioxanthene derivatives.
2008-05-30
Trends in hospital admissions for adverse drug reactions in England: analysis of national hospital episode statistics 1998-2005.
2007-09-25
Schisandrol A from Schisandra chinensis reverses P-glycoprotein-mediated multidrug resistance by affecting Pgp-substrate complexes.
2007-03
Remarkable interplay of redox states and conformational changes in a sterically crowded, cross-conjugated tetrathiafulvalene vinylog.
2006-07-17
Biochemical and pharmacological properties of an allosteric modulator site of the human P-glycoprotein (ABCB1).
2006-07-14
The interplay of inverted redox potentials and aromaticity in the oxidized states of new pi-electron donors: 9-(1,3-dithiol-2-ylidene)fluorene and 9-(1,3-dithiol-2-ylidene)thioxanthene derivatives.
2006-04-12
A system for precise analysis of transcription-regulating elements of immunoglobulin genes.
2005-10-04
Determination of mercaptopurine and its four metabolites by large-volume sample stacking with polarity switching in capillary electrophoresis.
2005-06
Thioxanthene-derived analogs as sigma(1) receptor ligands.
2004-05-03
A novel two-carbon homologation with N-vinylacetamides and ethyl vinyl ether as acetaldehyde anion equivalents in the synthesis of 9H-xanthene, 9H-thioxanthene, and 9,10-dihydro-9-acridine carboxaldehydes.
2004-01-23
Twin-rotor system created on a [4]radialene frame.
2003-09-18
Overcrowded 1,8-diazafluorenylidene-chalcoxanthenes. Introducing nitrogens at the fjord regions of bistricyclic aromatic enes.
2003-08-07
Zuclopenthixol facilitates memory retrieval in rats: possible involvement of noradrenergic and serotonergic mechanisms.
2003-07
Distinct tissue distribution of metabolites of the novel glutathione-activated thiopurine prodrugs cis-6-(2-acetylvinylthio)purine and trans-6-(2-acetylvinylthio)guanine and 6-thioguanine in the mouse.
2003-06
Allosteric modulation of human P-glycoprotein. Inhibition of transport by preventing substrate translocation and dissociation.
2003-05-16
Separation of (Z)- and (E)-isomers of thioxanthene and dibenz[b,e]oxepin derivatives with calixarenes and resorcinarenes as additives in nonaqueous capillary electrophoresis.
2003-05
Flupenthixol in relapse prevention in schizophrenics with comorbid alcoholism: results from an open clinical study.
2003-04
S-pixyl analogues as photocleavable protecting groups for nucleosides.
2002-11-01
The glutathione-activated thiopurine prodrugs trans-6-(2-acetylvinylthio)guanine and cis-6-(2-acetylvinylthio)purine cause less in vivo toxicity than 6-thioguanine after single- and multiple-dose regimens.
2002-11
Platelet serotonin transporter in schizophrenic patients with and without neuroleptic treatment.
2002-10
Inhibition of butyrylcholinesterase by phenothiazine derivatives.
2002-06
Priapism associated with zuclopenthixol.
2002-06
New approach to biomimetic transamination using bifunctional [1,3]-proton transfer catalysis in thioxanthenyl dioxide imines.
2002-05-31
Separation of cis- and trans-isomers of thioxanthene and dibenz[b,e]oxepin derivatives on calixarene- and resorcinarene-bonded high-performance liquid chromatography stationary phases.
2002-03-01
Long-term effects of the substituted benzamide derivative amisulpride on baseline and stimulated prolactin levels.
2002
Flow-injection chemiluminometric determination of some thioxanthene derivatives in pharmaceutical formulations and biological fluids using the [Ru(dipy)3(2+)]-Ce(IV) system.
2001-11
Nucleoside analogues as highly potent and selective inhibitors of herpes simplex virus thymidine kinase.
2001-07-09
DNA-dependent protein kinase is inhibited by trifluoperazine.
2001-05-18
Suspected induction of a pyoderma gangrenosum-like eruption due to sulpiride treatment.
2001-03
Zuclopenthixol acetate in the treatment of acute schizophrenia and similar serious mental illnesses.
2001
Zuclopenthixol treatment of behavioral disturbances in mentally retarded children and adolescents: an open-label study.
2001
Patents
Substance Class Chemical
Created
by admin
on Mon Mar 31 20:52:09 GMT 2025
Edited
by admin
on Mon Mar 31 20:52:09 GMT 2025
Record UNII
1J3P67894A
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
THIOXANTHINE
INCI  
INCI  
Official Name English
DIBENZOTHIAPYRAN
Preferred Name English
9H-THIOXANTHENE
Systematic Name English
THIOXANTHENE [MI]
Common Name English
THIOXANTHEN
Systematic Name English
Code System Code Type Description
ECHA (EC/EINECS)
205-972-1
Created by admin on Mon Mar 31 20:52:09 GMT 2025 , Edited by admin on Mon Mar 31 20:52:09 GMT 2025
PRIMARY
CAS
261-31-4
Created by admin on Mon Mar 31 20:52:09 GMT 2025 , Edited by admin on Mon Mar 31 20:52:09 GMT 2025
PRIMARY
CHEBI
51055
Created by admin on Mon Mar 31 20:52:09 GMT 2025 , Edited by admin on Mon Mar 31 20:52:09 GMT 2025
PRIMARY
WIKIPEDIA
Thioxanthene
Created by admin on Mon Mar 31 20:52:09 GMT 2025 , Edited by admin on Mon Mar 31 20:52:09 GMT 2025
PRIMARY
EPA CompTox
DTXSID20180732
Created by admin on Mon Mar 31 20:52:09 GMT 2025 , Edited by admin on Mon Mar 31 20:52:09 GMT 2025
PRIMARY
MERCK INDEX
m10792
Created by admin on Mon Mar 31 20:52:09 GMT 2025 , Edited by admin on Mon Mar 31 20:52:09 GMT 2025
PRIMARY Merck Index
PUBCHEM
67495
Created by admin on Mon Mar 31 20:52:09 GMT 2025 , Edited by admin on Mon Mar 31 20:52:09 GMT 2025
PRIMARY
CHEBI
51056
Created by admin on Mon Mar 31 20:52:09 GMT 2025 , Edited by admin on Mon Mar 31 20:52:09 GMT 2025
PRIMARY
MESH
C054700
Created by admin on Mon Mar 31 20:52:09 GMT 2025 , Edited by admin on Mon Mar 31 20:52:09 GMT 2025
PRIMARY
FDA UNII
1J3P67894A
Created by admin on Mon Mar 31 20:52:09 GMT 2025 , Edited by admin on Mon Mar 31 20:52:09 GMT 2025
PRIMARY